Is The Stock Market Rally Back On? The past few weeks have been a reminder that markets can change direction faster than investors can make sense of them.
GEO Shares Down 44% as Fund Sells $9 Million in Stock Amid ICE Allegations and Softer Outlook GEO’s latest quarter shows a company pulling in record contracts while wrestling with litigation and cooling earnings guidance—here’s what investors need to know.
U.S. Solvency Crisis, Market Top & The Real Risks Ahead Markets are near highs, valuations are stretched, and investors are nervous. At the same time, government debt and solvency risks are exploding.
Is Jim Cramer Calling Boeing's Bottom — Or Is The Stock Just Running On Pentagon Propellant? Boeing (BA) stock jumps 2.5% as Jim Cramer predicts a monstrous 2026 after company secures $7B in defense deals, but market remains cautious.
2025: The Year Of Alphabet No stock has seen a bigger jump recently than Alphabet, whose market cap has risen by more than half of a trillion dollars since 10/29.
FX Today: Focus Shifts To Inflation Data In Japan And Germany EUR/USD swung between gains and losses near the 1.1600 region following three consecutive daily advances.
Have You Heard of the ‘Wheel’ Strategy? These 3 Unusually Active Stocks to Buy Can Get You Started As you enjoy turkey and football on this Thanksgiving, here’s a look at an options strategy that’s a close cousin to the Covered Strangle. In Wednesday’s unusual options activity, these three stocks to buy can get you started.
Why JPMorgan Believes Oil Could Crash To $30 Over The Next Two Years While global oil demand is expected to rise steadily – by nearly 900,000 barrels per day in 2026 and 1.2 million barrels per day in 2027 – production is forecast to grow at triple that rate.
Why One Fund Made a $59 Million Bet on Semtech Stock as Shares Surge to Multi-Year Highs Semtech’s turnaround is gaining momentum—and one fund just made a sizable bet on what comes next.
Biotech Fund Dumps $12.3 Million in Crinetics Stock as Shares Remain 19% Lower on the Year Here’s what a complete fund exit reveals about sentiment toward one of biotech’s endocrine drug developers.
Top Reasons Tilray Stock Price Has More Downside To Go Tilray stock price has attempted to rebound this week as it rose in the last three consecutive days.
The FTSE Finish Line - Thursday, Nov. 27 The UK's FTSE 100 hugged the flatline on Thursday, weighed down by losses in the consumer staples and energy sectors.
Invest In U.S. Exceptionalism Private investments in U.S. tech companies in the first nine months of this year rose 95% to $177bn compared with a 7% increase to $33bn in the EU.
Visa Partners With Aquanow To Boost Stablecoin Use Across CEMEA Visa partners with Aquanow to expand USDC stablecoin settlements across CEMEA, aiming for faster, cheaper cross-border payments.
Is Philip Morris International Stock Outperforming the S&P 500? Philip Morris has outperformed the S&P 500 Index over the past year, and analysts are bullish about the stock’s growth prospects.
Here's Why One Fund Just Bet $46 Million on This Surging Printed Circuit Board Stock One semiconductor supplier’s surge in institutional demand is revealing where smart money expects the next leg of tech growth to unfold.
Silver Price Consolidates As USD Rebounds, Fed Rate Cut Outlook Supports Demand Silver (XAG/USD) drifts slightly lower on Thursday, trading around $53.25, down 0.15% on the day at the time of writing.
SEC Opens Civil Probe Into Jefferies Over $12B First Brands Collapse The SEC is investigating Jefferies over its disclosures tied to First Brands' $12B collapse, as CEO claims the firm was defrauded.
3 Dividend-paying Stocks That Are Up Over 30% In 2025 AbbVie, Amgen, and IBM are among 2025’s top dividend performers, each up more than 30% while offering solid yields and steady income.
This Small-Cap Consumer Stock Has Landed New Institutional Backing as Shares Surge 60% A fast-growing niche segment may be the real reason this small-cap consumer products stock is drawing new institutional attention.
